More than a dozen countries in the European Union have suspended distribution of AstraZeneca’s vaccine due to blood clot concerns, further complicating a vaccination effort that was already lagging across the region.
The call to pause the rollout is being questioned by some health experts, who say the data simply does not support the decision. It is “important to contextualize” what’s being reported because the risk of blood clots is no higher among vaccinated people than among the…
Source link
